FTRE · Fortrea Holdings Inc. · Webcasts, Transcripts & Audio
$19.40
-0.55 (-2.76%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$1.89B
Shares
95.10M
Volume · Oct 1
1.94M
Avg daily vol (3M)
1.41M
Fortrea Holdings Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Fortrea Holdings Inc. (FTRE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼8.6%
$725.10M
$30.80M
'23 Q2
23-08-14
▼6.4%
$713.80M
−$14.00M
'23 Q3
23-11-13
·
$709.70M
−$54.50M
'23 Q4
24-03-11
▼4.6%
$662.10M
−$101.00M
'24 Q1
24-05-13
▼8.6%
$662.40M
−$138.40M
'24 Q2
24-08-12
▼5.4%
$674.90M
−$27.90M
'24 Q3
24-11-08
▼1.8%
$697.00M
−$61.20M
'24 Q4
25-03-03
▼1.6%
$651.30M
−$562.90M
'25 Q1
25-05-12
▲7.2%
$710.30M
−$374.90M
'25 Q2
25-08-06
▲3.9%
$701.30M
−$15.90M
'25 Q3
25-11-05
▼5.2%
$660.50M
−$32.50M
'25 Q4
26-02-26
▼2.3%
$636.50M
−$23.60M
'26 Q1
26-05-05
LATEST
▼4.5%
$678.20M
−$13.20M
'26 Q2
26-07-29
Conference
Investor event
2026-11-19
Fortrea Holdings Inc. (FTRE) November 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-10-30
Fortrea Holdings Inc. (FTRE) October 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Annual General Meeting
Investor event
2026-10-20
Fortrea Holdings Inc. (FTRE) October 2026 Annual General Meeting
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-29
Fortrea Holdings Inc. (FTRE) Q2 2026 Earnings Call Transcript
Positive tone
Guidance raise / financial performance
Commercial excellence and book-to-bill
Therapeutic and geographic mix
Revenue
$678.20M
▼ 4.5% YoY Diluted EPS
$-0.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-04
Fortrea Holdings Inc. (FTRE) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript
Positive tone
Biotech demand recovery
Guidance and revenue conversion timing
Fortrea Intelligent Technology (FIT) launch
Revenue
$636.50M
▼ 2.3% YoY Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Fortrea Holdings Inc. (FTRE) Q4 2025 Earnings Call Transcript
Positive tone
Clinical pharmacology and FSP dynamics
Bookings and demand recovery
Commercial framework (3Rs)
Revenue
$660.50M*
▼ 5.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Fortrea Holdings Inc. (FTRE) Q3 2025 Earnings Call Transcript
Positive tone
FSP business and pricing discipline
Backlog and book-to-bill
Clinical pharmacology and new awards
Revenue
$701.30M
▲ 3.9% YoY Diluted EPS
$-0.17
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Fortrea Holdings Inc. (FTRE) Q2 2025 Earnings Call Transcript
Balanced tone
Margin optimization and cost initiatives
Guidance update
Bookings and book-to-bill weakness
Revenue
$710.30M
▲ 7.2% YoY Diluted EPS
$-4.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Fortrea Holdings Inc. (FTRE) Q1 2025 Earnings Call Transcript
Positive tone
Bookings and pipeline
SG&A cost reduction
Gross margin and project ramp
Revenue
$651.30M
▼ 1.6% YoY Diluted EPS
$-6.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-03
Fortrea Holdings Inc. (FTRE) Q4 2024 Earnings Call Transcript
Cautious tone
Pre-spin vs post-spin project economics
Book-to-bill and backlog growth
Clinical Pharmacology Services (CPS)
Revenue
$697.00M*
▼ 1.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-08
Fortrea Holdings Inc. (FTRE) Q3 2024 Earnings Call Transcript
Positive tone
Biotech and Large Pharma Mix
Bookings and Book-to-Bill
Clinical Pharmacology (CPS/Phase 1)
Revenue
$674.90M
▼ 5.4% YoY Diluted EPS
$-0.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Fortrea Holdings Inc. (FTRE) Q2 2024 Earnings Call Transcript
Positive tone
Biotech contracting unpredictability
Large pharma wins and pipeline
Book-to-bill and bookings shortfall
Revenue
$662.40M
▼ 8.6% YoY Diluted EPS
$-1.55
▼ 542.9% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Fortrea Holdings Inc. (FTRE) Q1 2024 Earnings Call Transcript
Balanced tone
Demand and Book-to-Bill
Commercial Transformation and Customer Mix
Capital Structure
Revenue
$662.10M
▼ 4.6% YoY Diluted EPS
$-1.13
▼ 907.1% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-11
Fortrea Holdings Inc. (FTRE) Q4 2023 Earnings Call Transcript
Positive tone
Bookings and commercial momentum
Spin-off completion and operating as standalone
Brand and demand generation
Revenue
$709.70M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Fortrea Holdings Inc. (FTRE) Q3 2023 Earnings Call Transcript
Revenue
$713.80M
▼ 6.4% YoY Diluted EPS
$-0.16
▼ 123.5% YoY
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Fortrea Holdings Inc. (FTRE) Q2 2023 Earnings Call Transcript
Revenue
$725.10M
▼ 8.6% YoY Diluted EPS
$0.35
▼ 53.3% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–17 of 17 webcasts